Patients relying on a temporary heart pump to stay alive face a direct threat: the FDA classified a recall of Abiomed’s ...

A new type of surgically implanted pump that can support a child's failing heart has passed the first stage of human testing in a recent trial. A small, implantable cardiac pump that could help ...

A third-party randomized trial from King’s College London is being cited as the reason Johnson & Johnson’s Impella usage has ...

An international trial of the Impella heart pump in patients with ST elevation myocardial infarction (STEMI) and cardiogenic shock has been stopped by the sponsor Abiomed, Inc. The termination ...

According to the World Health Organization, diseases of the circulatory system, including heart disease such as heart attacks, are still among the most common causes of death worldwide. Recovering the ...

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage. That is ...

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage. That is ...